{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:22:30Z","timestamp":1793110950639,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. B cells are believed to play a central role in the pathogenesis of IgAN by producing galactose-deficient IgA1 (Gd-IgA1), partly due to aberrant gene expression in B cells. However, the mechanisms underlying the abnormal gene expression in B cells derived from patients with IgAN remain elusive. Here we unveil a broad spectrum of variations in chromatin accessibility in B cells of patients with IgAN through an assay for transposase-accessible chromatin using sequencing (ATAC-seq) by evaluating active DNA regulatory components. A total of 629 genes showed transcriptional alterations associated with differentially chromatin accessibility. The degree of chromatin accessibility was associated with gene expression in peripheral blood B cells of patients with IgAN. Gene Ontology analysis of genes associated with differentially expressed genes and differentially accessible regions revealed enrichment in pathways related to the regulation of transcription. Furthermore, KLF4 was also identified as a key transcription factor promoting the production of IgA1 and Gd-IgA1. In vitro, knockdown of KLF4 suppressed the production of Gd-IgA1 in IgA-secreting cell lines. Through RNA sequencing, this study further showed that KLF4 could regulate the expression of genes related to the intestinal immune network for IgA production. Chromatin immunoprecipitation sequencing combined with RNA sequencing revealed that KLF4 could bind to the IL-6 promoter and regulate its expression. Mechanistically, a luciferase reporter assay verified that KLF4 directly bound to the\n                    <jats:italic>cis<\/jats:italic>\n                    -regulatory element of IL-6 and promoted its expression. The knockdown of KLF4 was shown to alleviate renal lesions and mesangial hypercellularity in IgAN mice. Collectively, the findings from this study elucidated a chromatin-mediated mechanism underlying the differential responses of B cells in IgAN and identified KLF4 as a potential therapeutic target of IgAN.\n                  <\/jats:p>","DOI":"10.1038\/s12276-025-01505-1","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T03:53:13Z","timestamp":1753242793000},"page":"1593-1606","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dynamics of chromatin accessibility governing Gd-IgA1 synthesis in B cells associated with IgA nephropathy"],"prefix":"10.1038","volume":"57","author":[{"given":"Yangang","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weicong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengchu","family":"Qing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6435-7303","authenticated-orcid":false,"given":"Manli","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongqiong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"1505_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.semnephrol.2018.05.013","volume":"38","author":"FP Schena","year":"2018","unstructured":"Schena, F. P. & Nistor, I. Epidemiology of IgA nephropathy: a global perspective. Semin Nephrol. 38, 435\u2013442 (2018).","journal-title":"Semin Nephrol."},{"key":"1505_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.1","volume":"2","author":"KN Lai","year":"2016","unstructured":"Lai, K. N. et al. IgA nephropathy. Nat. Rev. Dis. Prim. 2, 16001 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1505_CR3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2215\/CJN.0000000000000135","volume":"18","author":"D Pitcher","year":"2023","unstructured":"Pitcher, D. et al. Long-term outcomes in IgA nephropathy. Clin. J. Am. Soc. Nephrol. 18, 727\u2013738 (2023).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1505_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000519973","volume":"2","author":"K Scionti","year":"2022","unstructured":"Scionti, K. et al. New insights into the pathogenesis and treatment strategies in IgA nephropathy. Glomerular Dis. 2, 15\u201329 (2022).","journal-title":"Glomerular Dis."},{"key":"1505_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrneph.2015.208","volume":"12","author":"J Floege","year":"2016","unstructured":"Floege, J. & Feehally, J. The mucosa\u2013kidney axis in IgA nephropathy. Nat. Rev. Nephrol. 12, 147\u2013156 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"1505_CR6","first-page":"629","volume":"118","author":"H Suzuki","year":"2008","unstructured":"Suzuki, H. et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J. Clin. Invest. 118, 629\u2013639 (2008).","journal-title":"J. Clin. Invest."},{"key":"1505_CR7","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1681\/ASN.2006060658","volume":"17","author":"AC Smith","year":"2006","unstructured":"Smith, A. C. et al. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. J. Am. Soc. Nephrol. 17, 3520\u20133528 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1505_CR8","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.kint.2019.08.022","volume":"97","author":"Y Makita","year":"2020","unstructured":"Makita, Y. et al. TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy. Kidney Int. 97, 340\u2013349 (2020).","journal-title":"Kidney Int."},{"key":"1505_CR9","doi-asserted-by":"publisher","first-page":"e136965","DOI":"10.1172\/jci.insight.136965","volume":"5","author":"N Zheng","year":"2020","unstructured":"Zheng, N. et al. TLR7 in B cells promotes renal inflammation and Gd-IgA1 synthesis in IgA nephropathy. JCI Insight 5, e136965 (2020).","journal-title":"JCI Insight"},{"key":"1505_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13578-021-00706-1","volume":"11","author":"H Zeng","year":"2021","unstructured":"Zeng, H. et al. Single-cell RNA-sequencing reveals distinct immune cell subsets and signaling pathways in IgA nephropathy. Cell Biosci. 11, 203 (2021).","journal-title":"Cell Biosci."},{"key":"1505_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.901465","volume":"13","author":"W Du","year":"2022","unstructured":"Du, W. et al. Increased proportion of follicular helper T cells is associated with B cell activation and disease severity in IgA nephropathy. Front. Immunol. 13, 901465 (2022).","journal-title":"Front. Immunol."},{"key":"1505_CR12","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nrg.2016.98","volume":"17","author":"N Moris","year":"2016","unstructured":"Moris, N., Pina, C. & Arias, A. M. Transition states and cell fate decisions in epigenetic landscapes. Nat. Rev. Genet. 17, 693\u2013703 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"1505_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41594-019-0368-x","volume":"27","author":"S Baldi","year":"2020","unstructured":"Baldi, S., Korber, P. & Becker, P. B. Beads on a string\u2013nucleosome array arrangements and folding of the chromatin fiber. Nat. Struct. Mol. Biol. 27, 109\u2013118 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1505_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41576-018-0089-8","volume":"20","author":"SL Klemm","year":"2019","unstructured":"Klemm, S. L., Shipony, Z. & Greenleaf, W. J. Chromatin accessibility and the regulatory epigenome. Nat. Rev. Genet. 20, 207\u2013220 (2019).","journal-title":"Nat. Rev. Genet."},{"key":"1505_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00005-023-00677-w","volume":"71","author":"K Mucha","year":"2023","unstructured":"Mucha, K., Pac, M. & Paczek, L. Omics are getting us closer to understanding IgA nephropathy. Arch. Immunol. Ther. Exp. 71, 12 (2023).","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"1505_CR16","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"Kidney Disease: Improving Global Outcomes Glomerular Diseases Work Group.","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 100, S1\u2013S276 (2021).","journal-title":"Kidney Int."},{"key":"1505_CR17","doi-asserted-by":"publisher","first-page":"21 9 1","DOI":"10.1002\/0471142727.mb2129s109","volume":"109","author":"JD Buenrostro","year":"2015","unstructured":"Buenrostro, J. D. et al. ATAC-seq: a method for assaying chromatin accessibility genome-wide. Curr. Protoc. Mol. Biol. 109, 21 9 1\u201321 9 (2015).","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"1505_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-1-4939-0512-6_4","volume":"1150","author":"T Liu","year":"2014","unstructured":"Liu, T. Use model-based analysis of ChIP-seq (MACS) to analyze short reads generated by sequencing protein\u2013DNA interactions in embryonic stem cells. Methods Mol. Biol. 1150, 81\u201395 (2014).","journal-title":"Methods Mol. Biol."},{"key":"1505_CR19","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576\u2013589 (2010).","journal-title":"Mol. Cell"},{"key":"1505_CR20","doi-asserted-by":"publisher","first-page":"9621","DOI":"10.1093\/nar\/gkaa711","volume":"48","author":"H Zhao","year":"2020","unstructured":"Zhao, H. et al. A role of the CTCF binding site at enhancer E\u03b1 in the dynamic chromatin organization of the Tcra-Tcrd locus. Nucleic Acids Res. 48, 9621\u20139636 (2020).","journal-title":"Nucleic Acids Res."},{"key":"1505_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.900963","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang, W. et al. Orange-derived and dexamethasone-encapsulated extracellular vesicles reduced proteinuria and alleviated pathological lesions in IgA nephropathy by targeting intestinal lymphocytes. Front. Immunol. 13, 900963 (2022).","journal-title":"Front. Immunol."},{"key":"1505_CR22","first-page":"6","volume":"005","author":"ZH Liu","year":"1989","unstructured":"Liu, Z. H. & Li, L. S. Staphylococcal enterotoxin induced IgA nephropathy model. Chin. J. Nephrol. 005, 6\u201310 (1989).","journal-title":"Chin. J. Nephrol."},{"key":"1505_CR23","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1080\/0886022X.2022.2079527","volume":"44","author":"Q Wan","year":"2022","unstructured":"Wan, Q. et al. TNF-\u03b1-mediated podocyte injury via the apoptotic death receptor pathway in a mouse model of IgA nephropathy. Ren. Fail. 44, 1216\u20131226 (2022).","journal-title":"Ren. Fail."},{"key":"1505_CR24","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.1128\/JVI.00254-08","volume":"82","author":"D Grimm","year":"2008","unstructured":"Grimm, D. et al. In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses. J. Virol. 82, 5887\u20135911 (2008).","journal-title":"J. Virol."},{"key":"1505_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ymthe.2004.04.005","volume":"10","author":"T Moreau","year":"2004","unstructured":"Moreau, T. et al. Restriction of transgene expression to the B-lymphoid progeny of human lentivirally transduced CD34+ cells. Mol. Ther. 10, 45\u201356 (2004).","journal-title":"Mol. Ther."},{"key":"1505_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1159\/000441506","volume":"42","author":"H Chen","year":"2015","unstructured":"Chen, H. et al. Lipopolysaccharide induces chronic kidney injury and fibrosis through activation of mTOR signaling in macrophages. Am. J. Nephrol. 42, 305\u2013317 (2015).","journal-title":"Am. J. Nephrol."},{"key":"1505_CR27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41588-020-00768-w","volume":"53","author":"M Iurlaro","year":"2021","unstructured":"Iurlaro, M. et al. Mammalian SWI\/SNF continuously restores local accessibility to chromatin. Nat. Genet. 53, 279\u2013287 (2021).","journal-title":"Nat. Genet."},{"key":"1505_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2007-8-2-r24","volume":"8","author":"S Gupta","year":"2007","unstructured":"Gupta, S. et al. Quantifying similarity between motifs. Genome Biol. 8, R24 (2007).","journal-title":"Genome Biol."},{"key":"1505_CR29","doi-asserted-by":"crossref","unstructured":"Zhong, Z. et al. Association of TNFSF13 polymorphisms with IgA nephropathy in a Chinese Han population. J. Gene Med. 19, (2017).","DOI":"10.1002\/jgm.2966"},{"key":"1505_CR30","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.kint.2023.08.013","volume":"104","author":"M Lee","year":"2023","unstructured":"Lee, M. et al. The nucleotide-sensing Toll-like receptor 9\/Toll-like receptor 7 system is a potential therapeutic target for IgA nephropathy. Kidney Int. 104, 943\u2013955 (2023).","journal-title":"Kidney Int."},{"key":"1505_CR31","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202051644","volume":"22","author":"D Li","year":"2021","unstructured":"Li, D. et al. Chromatin accessibility dynamics during cell fate reprogramming. EMBO Rep. 22, e51644 (2021).","journal-title":"EMBO Rep."},{"key":"1505_CR32","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1126\/science.1256271","volume":"345","author":"D Lara-Astiaso","year":"2014","unstructured":"Lara-Astiaso, D. et al. Immunogenetics. Chromatin state dynamics during blood formation. Science 345, 943\u2013949 (2014).","journal-title":"Science"},{"key":"1505_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13072-019-0260-2","volume":"12","author":"RR Starks","year":"2019","unstructured":"Starks, R. R. et al. Combined analysis of dissimilar promoter accessibility and gene expression profiles identifies tissue-specific genes and actively repressed networks. Epigenetics Chromatin 12, 16 (2019).","journal-title":"Epigenetics Chromatin"},{"key":"1505_CR34","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/nature18606","volume":"534","author":"J Wu","year":"2016","unstructured":"Wu, J. et al. The landscape of accessible chromatin in mammalian preimplantation embryos. Nature 534, 652\u2013657 (2016).","journal-title":"Nature"},{"key":"1505_CR35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000512169","volume":"7","author":"M Wei","year":"2021","unstructured":"Wei, M. et al. Monozygotic twins discordant for immunoglobulin A nephropathy display differences in DNA methylation and gene expression. Kidney Dis. 7, 200\u2013209 (2021).","journal-title":"Kidney Dis."},{"key":"1505_CR36","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/aps.2015.79","volume":"37","author":"Q Dai","year":"2016","unstructured":"Dai, Q. et al. Histone deacetylase inhibitors attenuate P-aIgA1-induced cell proliferation and extracellular matrix synthesis in human renal mesangial cells in vitro. Acta Pharm. Sin. 37, 228\u2013234 (2016).","journal-title":"Acta Pharm. Sin."},{"key":"1505_CR37","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s40620-022-01498-4","volume":"36","author":"SP Kademani","year":"2023","unstructured":"Kademani, S. P. et al. Noncoding RNAs associated with IgA nephropathy. J. Nephrol. 36, 911\u2013923 (2023).","journal-title":"J. Nephrol."},{"key":"1505_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.gene.2017.02.025","volume":"611","author":"AM Ghaleb","year":"2017","unstructured":"Ghaleb, A. M. & Yang, V. W. Kruppel-like factor 4 (KLF4): what we currently know. Gene 611, 27\u201337 (2017).","journal-title":"Gene"},{"key":"1505_CR39","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/ki.2015.178","volume":"88","author":"K Hayashi","year":"2015","unstructured":"Hayashi, K. et al. Renin\u2013angiotensin blockade resets podocyte epigenome through Kruppel-like factor 4 and attenuates proteinuria. Kidney Int. 88, 745\u2013753 (2015).","journal-title":"Kidney Int."},{"key":"1505_CR40","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/s41401-020-0463-x","volume":"42","author":"D Xu","year":"2021","unstructured":"Xu, D. et al. KLF4 initiates sustained YAP activation to promote renal fibrosis in mice after ischemia-reperfusion kidney injury. Acta Pharm. Sin. 42, 436\u2013450 (2021).","journal-title":"Acta Pharm. Sin."},{"key":"1505_CR41","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1681\/ASN.2019020111","volume":"30","author":"Y Wen","year":"2019","unstructured":"Wen, Y. et al. KLF4 in macrophages attenuates TNF\u03b1-mediated kidney injury and fibrosis. J. Am. Soc. Nephrol. 30, 1925\u20131938 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1505_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-52581-8","volume":"14","author":"S Park","year":"2024","unstructured":"Park, S. et al. Glomerular spatial transcriptomics of IgA nephropathy according to the presence of mesangial proliferation. Sci. Rep. 14, 2211 (2024).","journal-title":"Sci. Rep."},{"key":"1505_CR43","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1189\/jlb.0811413","volume":"91","author":"CS Park","year":"2012","unstructured":"Park, C. S. et al. Kruppel-like factor 4 (KLF4) promotes the survival of natural killer cells and maintains the number of conventional dendritic cells in the spleen. J. Leukoc. Biol. 91, 739\u2013750 (2012).","journal-title":"J. Leukoc. Biol."},{"key":"1505_CR44","doi-asserted-by":"crossref","unstructured":"Ou, D. L. et al. Regorafenib enhances antitumor immunity via inhibition of p38 kinase\/Creb1\/Klf4 axis in tumor-associated macrophages. J. Immunother. Cancer 9, (2021).","DOI":"10.1136\/jitc-2020-001657"},{"key":"1505_CR45","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.4049\/jimmunol.179.7.4679","volume":"179","author":"J Klaewsongkram","year":"2007","unstructured":"Klaewsongkram, J. et al. Kruppel-like factor 4 regulates B cell number and activation-induced B cell proliferation. J. Immunol. 179, 4679\u20134684 (2007).","journal-title":"J. Immunol."},{"key":"1505_CR46","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1080\/15384101.2016.1191709","volume":"15","author":"M Schoenhals","year":"2016","unstructured":"Schoenhals, M. et al. Forced KLF4 expression increases the generation of mature plasma cells and uncovers a network linked with plasma cell stage. Cell Cycle 15, 1919\u20131928 (2016).","journal-title":"Cell Cycle"},{"key":"1505_CR47","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/s41588-023-01422-x","volume":"55","author":"K Kiryluk","year":"2023","unstructured":"Kiryluk, K. et al. Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy. Nat. Genet. 55, 1091\u20131105 (2023).","journal-title":"Nat. Genet."},{"key":"1505_CR48","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.cell.2012.09.045","volume":"151","author":"A Soufi","year":"2012","unstructured":"Soufi, A., Donahue, G. & Zaret, K. S. Facilitators and impediments of the pluripotency reprogramming factors\u2019 initial engagement with the genome. Cell 151, 994\u20131004 (2012).","journal-title":"Cell"},{"key":"1505_CR49","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.4049\/jimmunol.143.7.2230","volume":"143","author":"DY Kunimoto","year":"1989","unstructured":"Kunimoto, D. Y., Nordan, R. P. & Strober, W. IL-6 is a potent cofactor of IL-1 in IgM synthesis and of IL-5 in IgA synthesis. J. Immunol. 143, 2230\u20132235 (1989).","journal-title":"J. Immunol."},{"key":"1505_CR50","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1084\/jem.169.6.2133","volume":"169","author":"KW Beagley","year":"1989","unstructured":"Beagley, K. W. et al. Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J. Exp. Med. 169, 2133\u20132148 (1989).","journal-title":"J. Exp. Med."},{"key":"1505_CR51","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1126\/science.8160012","volume":"264","author":"AJ Ramsay","year":"1994","unstructured":"Ramsay, A. J. et al. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264, 561\u2013563 (1994).","journal-title":"Science"},{"key":"1505_CR52","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1126\/science.1176676","volume":"325","author":"RI Nurieva","year":"2009","unstructured":"Nurieva, R. I. et al. Bcl6 mediates the development of T follicular helper cells. Science 325, 1001\u20131005 (2009).","journal-title":"Science"},{"key":"1505_CR53","doi-asserted-by":"publisher","first-page":"313","DOI":"10.4049\/jimmunol.0904023","volume":"185","author":"AC Poholek","year":"2010","unstructured":"Poholek, A. C. et al. In vivo regulation of Bcl6 and T follicular helper cell development. J. Immunol. 185, 313\u2013326 (2010).","journal-title":"J. Immunol."},{"key":"1505_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01742-7","volume":"8","author":"JS Fang","year":"2017","unstructured":"Fang, J. S. et al. Shear-induced Notch\u2013Cx37\u2013p27 axis arrests endothelial cell cycle to enable arterial specification. Nat. Commun. 8, 2149 (2017).","journal-title":"Nat. Commun."},{"key":"1505_CR55","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.1074\/jbc.M113.512277","volume":"289","author":"H Suzuki","year":"2014","unstructured":"Suzuki, H. et al. Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes. J. Biol. Chem. 289, 5330\u20135339 (2014).","journal-title":"J. Biol. Chem."},{"key":"1505_CR56","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1093\/ndt\/gfq325","volume":"25","author":"K Yamada","year":"2010","unstructured":"Yamada, K. et al. Down-regulation of core 1 \u03b21,3-galactosyltransferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1. Nephrol. Dial. Transpl. 25, 3890\u20133897 (2010).","journal-title":"Nephrol. Dial. Transpl."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01505-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01505-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01505-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T21:18:05Z","timestamp":1757279885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01505-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":56,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["1505"],"URL":"https:\/\/doi.org\/10.1038\/s12276-025-01505-1","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"27 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}